4.7 Article

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

Journal

JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 13, Pages -

Publisher

MDPI
DOI: 10.3390/jcm10132885

Keywords

epidemiology; incidence; inflammatory bowel disease; Crohn's disease; ulcerative colitis

Funding

  1. Instituto de Salud Carlos III (FIS grant) [PI16/01296, PFI17/00143]
  2. GETECCU (Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
  3. MSD

Ask authors/readers for more resources

The study found a high incidence of inflammatory bowel disease (IBD) in Spain, similar to that reported in Northern Europe. IBD patients require substantial therapeutic resources, especially in cases of Crohn's disease (CD) and in hospitals with high resources, which are much higher than previously reported.
(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe the main epidemiological and clinical characteristics at diagnosis and the evolution of the disease, and to explore the use of drug treatments. (2) Methods: Prospective, population-based nationwide registry. Adult patients diagnosed with IBD-Crohn's disease (CD), ulcerative colitis (UC) or IBD unclassified (IBD-U)-during 2017 in Spain were included and were followed-up for 1 year. (3) Results: We identified 3611 incident cases of IBD diagnosed during 2017 in 108 hospitals covering over 22 million inhabitants. The overall incidence (cases/100,000 person-years) was 16 for IBD, 7.5 for CD, 8 for UC, and 0.5 for IBD-U; 53% of patients were male and median age was 43 years (interquartile range = 31-56 years). During a median 12-month follow-up, 34% of patients were treated with systemic steroids, 25% with immunomodulators, 15% with biologics and 5.6% underwent surgery. The percentage of patients under these treatments was significantly higher in CD than UC and IBD-U. Use of systemic steroids and biologics was significantly higher in hospitals with high resources. In total, 28% of patients were hospitalized (35% CD and 22% UC patients, p < 0.01). (4) Conclusion: The incidence of IBD in Spain is rather high and similar to that reported in Northern Europe. IBD patients require substantial therapeutic resources, which are greater in CD and in hospitals with high resources, and much higher than previously reported. One third of patients are hospitalized in the first year after diagnosis and a relevant proportion undergo surgery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available